{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:53:55Z","timestamp":1781654035275,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05184-0","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:55:57Z","timestamp":1781628957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexmedetomidine use in Infants undergoing Cooling due to neonatal Encephalopathy (DICE trial): safety and pharmacokinetics"],"prefix":"10.1038","author":[{"given":"Mariana C.","family":"Baserga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara L.","family":"DuPont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Ostrander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick B.","family":"Gerday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Yellepeddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"5184_CR1","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","volume":"375","author":"RE Black","year":"2010","unstructured":"Black, R. E. et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375, 1969\u20131987 (2010).","journal-title":"Lancet"},{"key":"5184_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk, J. J., White-Koning, M. & Badawi, N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum. Dev. 86, 329\u2013338 (2010).","journal-title":"Early Hum. Dev."},{"key":"5184_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.clp.2016.05.001","volume":"43","author":"S Ariff","year":"2016","unstructured":"Ariff, S., Lee, A. C., Lawn, J. & Bhutta, Z. A. Global Burden, epidemiologic trends, and prevention of intrapartum-related deaths in low-resource settings. Clin. Perinatol. 43, 593\u2013608 (2016).","journal-title":"Clin. Perinatol."},{"key":"5184_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran, S. et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 353, 1574\u20131584 (2005).","journal-title":"N. Engl. J. Med."},{"key":"5184_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi, D. V. et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N. Engl. J. Med. 361, 1349\u20131358 (2009).","journal-title":"N. Engl. J. Med."},{"key":"5184_CR6","doi-asserted-by":"crossref","unstructured":"Edwards, A.D. et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 340, c363 (2010).","DOI":"10.1136\/bmj.c363"},{"key":"5184_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fped.2020.00030","volume":"8","author":"MD Williams","year":"2020","unstructured":"Williams, M. D. & Lascelles, B. D. X. Early neonatal pain\u2014a review of clinical and experimental implications on painful conditions later in life. Front. Pediatr. 8, 30 (2020).","journal-title":"Front. Pediatr."},{"key":"5184_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41390-019-0371-2","volume":"85","author":"SL Bonifacio","year":"2019","unstructured":"Bonifacio, S. L. et al. Differences in patient characteristics and care practices between two trials of therapeutic hypothermia. Pediatr. Res. 85, 1008\u20131015 (2019).","journal-title":"Pediatr. Res."},{"key":"5184_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41372-018-0126-7","volume":"38","author":"G Natarajan","year":"2018","unstructured":"Natarajan, G. et al. Association between sedation-analgesia and neurodevelopment outcomes in neonatal hypoxic-ischemic encephalopathy. J. Perinatol. 38, 1060\u20131067 (2018).","journal-title":"J. Perinatol."},{"key":"5184_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4037\/ccn2021637","volume":"41","author":"M Moreda","year":"2021","unstructured":"Moreda, M., Beacham, P. S., Reese, A. & Mulkey, M. A. Increasing the effectiveness of targeted temperature management. Crit. Care Nurse 41, 59\u201363 (2021).","journal-title":"Crit. Care Nurse"},{"key":"5184_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpeds.2013.10.002","volume":"164","author":"C Chrysostomou","year":"2014","unstructured":"Chrysostomou, C. et al. A phase II\/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J. Pediatr. 164, 276\u2013282.e271\u2013273 (2014).","journal-title":"J. Pediatr."},{"key":"5184_CR12","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1055\/s-0038-1669938","volume":"8","author":"K O\u2019Mara","year":"2018","unstructured":"O\u2019Mara, K. & Weiss, M. D. Dexmedetomidine for sedation of neonates with hie undergoing therapeutic hypothermia: a single-center experience. AJP Rep. 8, e168\u2013e173 (2018).","journal-title":"AJP Rep."},{"key":"5184_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0885066608324389","volume":"23","author":"JD Tobias","year":"2008","unstructured":"Tobias, J. D. Bradycardia during dexmedetomidine and therapeutic hypothermia. J. Intensive Care Med 23, 403\u2013408 (2008).","journal-title":"J. Intensive Care Med"},{"key":"5184_CR14","doi-asserted-by":"crossref","unstructured":"Cosnahan, A.S., Angert, R.M., Jano, E. & Wachtel, E.V. Dexmedetomidine versus intermittent morphine for sedation of neonates with encephalopathy undergoing therapeutic hypothermia. J. Perinatol. 41, 2284\u20132291 (2021).","DOI":"10.1038\/s41372-021-00998-8"},{"key":"5184_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/ther.2016.0003","volume":"6","author":"KB Anderson","year":"2016","unstructured":"Anderson, K. B., Poloyac, S. M., Kochanek, P. M. & Empey, P. E. Effect of hypothermia and targeted temperature management on drug disposition and response following cardiac arrest: a comprehensive review of preclinical and clinical investigations. Ther. Hypothermia Temp. Manag 6, 169\u2013179 (2016).","journal-title":"Ther. Hypothermia Temp. Manag"},{"key":"5184_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jp.2010.146","volume":"31","author":"S Zanelli","year":"2011","unstructured":"Zanelli, S., Buck, M. & Fairchild, K. Physiologic and pharmacologic considerations for hypothermia therapy in neonates. J. Perinatol. 31, 377\u2013386 (2011).","journal-title":"J. Perinatol."},{"key":"5184_CR17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns, G. L. et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 349, 1157\u20131167 (2003).","journal-title":"N. Engl. J. Med."},{"key":"5184_CR18","doi-asserted-by":"crossref","unstructured":"Baserga, M. et al. Dexmedetomidine use in Infants undergoing Cooling due to neonatal Encephalopathy (DICE trial): a randomized controlled trial: background, aims and study protocol. Front. Pain Res. 2, 770511 (2021).","DOI":"10.3389\/fpain.2021.770511"},{"key":"5184_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/sj.jp.7211861","volume":"28","author":"P Hummel","year":"2008","unstructured":"Hummel, P., Puchalski, M., Creech, S. D. & Weiss, M. G. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J. Perinatol. 28, 55\u201360 (2008).","journal-title":"J. Perinatol."},{"key":"5184_CR20","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1161\/STROKEAHA.108.523654","volume":"39","author":"N Badjatia","year":"2008","unstructured":"Badjatia, N. et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke 39, 3242\u20133247 (2008).","journal-title":"Stroke"},{"key":"5184_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2019.104828","volume":"137","author":"IL Uner","year":"2019","unstructured":"Uner, I. L. et al. Therapeutic hypothermia and N-PASS; results from implementation in a level 3 NICU. Early Hum. Dev. 137, 104828 (2019).","journal-title":"Early Hum. Dev."},{"key":"5184_CR22","doi-asserted-by":"crossref","unstructured":"Jacobs, S.E. et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev. 2013, CD003311 (2013).","DOI":"10.1002\/14651858.CD003311.pub3"},{"key":"5184_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/pr.2015.101","volume":"78","author":"MC Baserga","year":"2015","unstructured":"Baserga, M. C. et al. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial. Pediatr. Res. 78, 315\u2013322 (2015).","journal-title":"Pediatr. Res."},{"key":"5184_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/brainsci4020321","volume":"4","author":"S Attarian","year":"2014","unstructured":"Attarian, S. et al. The neurodevelopmental impact of neonatal morphine administration. Brain Sci. 4, 321\u2013334 (2014).","journal-title":"Brain Sci."},{"key":"5184_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2796.2005.01569.x","volume":"259","author":"PE Molina","year":"2006","unstructured":"Molina, P. E. Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness. J. Intern. Med. 259, 138\u2013154 (2006).","journal-title":"J. Intern. Med."},{"key":"5184_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.siny.2014.10.003","volume":"20","author":"G Wassink","year":"2015","unstructured":"Wassink, G. et al. Analgesics, sedatives, anticonvulsant drugs, and the cooled brain. Semin. Fetal Neonatal Med. 20, 109\u2013114 (2015).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"5184_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1203\/00006450-200109000-00017","volume":"50","author":"M Thoresen","year":"2001","unstructured":"Thoresen, M. et al. Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective. Pediatr. Res. 50, 405\u2013411 (2001).","journal-title":"Pediatr. Res."},{"key":"5184_CR28","first-page":"CD015023","volume":"11","author":"P Backe","year":"2022","unstructured":"Backe, P., Bruschettini, M., Sibrecht, G., Thernstrom Blomqvist, Y. & Olsson, E. Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia. Cochrane Database Syst. Rev. 11, CD015023 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"5184_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41372-019-0533-4","volume":"40","author":"MW Berube","year":"2020","unstructured":"Berube, M. W. et al. Opioid and benzodiazepine use during therapeutic hypothermia in encephalopathic neonates. J. Perinatol. 40, 79\u201388 (2020).","journal-title":"J. Perinatol."},{"key":"5184_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa2119660","volume":"387","author":"YW Wu","year":"2022","unstructured":"Wu, Y. W. et al. Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns. N. Engl. J. Med. 387, 148\u2013159 (2022).","journal-title":"N. Engl. J. Med."},{"key":"5184_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0028-3908(02)00030-8","volume":"42","author":"S Hu","year":"2002","unstructured":"Hu, S., Sheng, W. S., Lokensgard, J. R. & Peterson, P. K. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42, 829\u2013836 (2002).","journal-title":"Neuropharmacology"},{"key":"5184_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijdevneu.2013.02.009","volume":"31","author":"D Bajic","year":"2013","unstructured":"Bajic, D., Commons, K. G. & Soriano, S. G. Morphine-enhanced apoptosis in selective brain regions of neonatal rats. Int. J. Dev. Neurosci. 31, 258\u2013266 (2013).","journal-title":"Int. J. Dev. Neurosci."},{"key":"5184_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1203\/PDR.0b013e31820bd165","volume":"69","author":"SE Juul","year":"2011","unstructured":"Juul, S. E., Beyer, R. P., Bammler, T. K., Farin, F. M. & Gleason, C. A. Effects of neonatal stress and morphine on murine hippocampal gene expression. Pediatr. Res. 69, 285\u2013292 (2011).","journal-title":"Pediatr. Res."},{"key":"5184_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000165379","volume":"95","author":"JF Boasen","year":"2009","unstructured":"Boasen, J. F., McPherson, R. J., Hays, S. L., Juul, S. E. & Gleason, C. A. Neonatal stress or morphine treatment alters adult mouse conditioned place preference. Neonatology 95, 230\u2013239 (2009).","journal-title":"Neonatology"},{"key":"5184_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000100084","volume":"92","author":"RJ McPherson","year":"2007","unstructured":"McPherson, R. J. et al. A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats. Neonatology 92, 33\u201341 (2007).","journal-title":"Neonatology"},{"key":"5184_CR36","first-page":"232","volume":"29","author":"C Acun","year":"2024","unstructured":"Acun, C. et al. Effectiveness and safety of dexmedetomidine in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J. Pediatr. Pharm. Ther. 29, 232\u2013240 (2024).","journal-title":"J. Pediatr. Pharm. Ther."},{"key":"5184_CR37","doi-asserted-by":"crossref","unstructured":"Lewis, S.R., Nicholson, A., Smith, A.F. & Alderson, P. Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia. Cochrane Database Syst. Rev. 2015, CD011107 (2015).","DOI":"10.1002\/14651858.CD011107.pub2"},{"key":"5184_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00246-012-0227-6","volume":"33","author":"F Lam","year":"2012","unstructured":"Lam, F. et al. Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease. Pediatr. Cardiol. 33, 1069\u20131077 (2012).","journal-title":"Pediatr. Cardiol."},{"key":"5184_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.273.5276.801","volume":"273","author":"LB MacMillan","year":"1996","unstructured":"MacMillan, L. B., Hein, L., Smith, M. S., Piascik, M. T. & Limbird, L. E. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 273, 801\u2013803 (1996).","journal-title":"Science"},{"key":"5184_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","volume":"93","author":"TJ Ebert","year":"2000","unstructured":"Ebert, T. J., Hall, J. E., Barney, J. A., Uhrich, T. D. & Colinco, M. D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93, 382\u2013394 (2000).","journal-title":"Anesthesiology"},{"key":"5184_CR41","first-page":"112","volume":"20","author":"LM Estkowski","year":"2015","unstructured":"Estkowski, L. M., Morris, J. L. & Sinclair, E. A. Characterization of dexmedetomidine dosing and safety in neonates and infants. J. Pediatr. Pharm. Ther. 20, 112\u2013118 (2015).","journal-title":"J. Pediatr. Pharm. Ther."},{"key":"5184_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00000542-199710000-00017","volume":"87","author":"P Talke","year":"1997","unstructured":"Talke, P. et al. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology 87, 835\u2013841 (1997).","journal-title":"Anesthesiology"},{"key":"5184_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jclinane.2006.08.011","volume":"19","author":"JC Finkel","year":"2007","unstructured":"Finkel, J. C. & Quezado, Z. M. Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J. Clin. Anesth. 19, 290\u2013292 (2007).","journal-title":"J. Clin. Anesth."},{"key":"5184_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000546017","volume":"122","author":"E Cocchi","year":"2025","unstructured":"Cocchi, E. et al. Dexmedetomidine as a promising neuroprotective sedoanalgesic in neonatal therapeutic hypothermia: a systematic review and meta-analysis. Neonatology 122, 495\u2013504 (2025).","journal-title":"Neonatology"},{"key":"5184_CR45","first-page":"22","volume":"7","author":"D Surkov","year":"2019","unstructured":"Surkov, D. Is dexmedetomidine a potential neuroprotective agent for term neonates with hypoxic-ischemic encephalopathy?. Pediatr. Anesth. Crit. Care J. 7, 22\u201330 (2019).","journal-title":"Pediatr. Anesth. Crit. Care J."},{"key":"5184_CR46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/aas.12318","volume":"58","author":"M Ezzati","year":"2014","unstructured":"Ezzati, M. et al. Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model. Acta Anaesthesiol. Scand. 58, 733\u2013742 (2014).","journal-title":"Acta Anaesthesiol. Scand."},{"key":"5184_CR47","first-page":"2582965","volume":"2020","author":"RM McAdams","year":"2020","unstructured":"McAdams, R. M., Pak, D., Lalovic, B., Phillips, B. & Shen, D. D. Dexmedetomidine pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Anesthesiol. Res Pr. 2020, 2582965 (2020).","journal-title":"Anesthesiol. Res Pr."},{"key":"5184_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","volume":"62","author":"D Morales Castro","year":"2023","unstructured":"Morales Castro, D., Dresser, L., Granton, J. & Fan, E. Pharmacokinetic alterations associated with critical illness. Clin. Pharmacokinet. 62, 209\u2013220 (2023).","journal-title":"Clin. Pharmacokinet."},{"key":"5184_CR49","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.2174\/1381612821666150901110929","volume":"21","author":"P Pokorna","year":"2015","unstructured":"Pokorna, P., Wildschut, E. D., Vobruba, V., van den Anker, J. N. & Tibboel, D. The impact of hypothermia on the pharmacokinetics of drugs used in neonates and young infants. Curr. Pharm. Des. 21, 5705\u20135724 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"5184_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jpeds.2017.08.048","volume":"192","author":"D Avant","year":"2018","unstructured":"Avant, D., Wharton, G. T. & Murphy, D. Characteristics and changes of pediatric therapeutic trials under the best pharmaceuticals for children act. J. Pediatr. 192, 8\u201312 (2018).","journal-title":"J. Pediatr."},{"key":"5184_CR51","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2174\/1574884709666140520153308","volume":"9","author":"J Autmizguine","year":"2014","unstructured":"Autmizguine, J. et al. Pharmacokinetic studies in infants using minimal-risk study designs. Curr. Clin. Pharm. 9, 350\u2013358 (2014).","journal-title":"Curr. Clin. Pharm."},{"key":"5184_CR52","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10928-018-9576-y","volume":"45","author":"SH Dallefeld","year":"2018","unstructured":"Dallefeld, S. H. et al. A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data. J. Pharmacokinet. Pharmacodyn. 45, 419\u2013430 (2018).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"5184_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/clpt.2014.134","volume":"96","author":"D Gonzalez","year":"2014","unstructured":"Gonzalez, D. et al. Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents. Clin. Pharm. Ther. 96, 429\u2013437 (2014).","journal-title":"Clin. Pharm. Ther."},{"key":"5184_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.xphs.2018.10.033","volume":"108","author":"M Grimstein","year":"2019","unstructured":"Grimstein, M. et al. Physiologically based pharmacokinetic modeling in regulatory science: an update from the U.S. Food and Drug Administration\u2019s Office of Clinical Pharmacology. J. Pharm. Sci. 108, 21\u201325 (2019).","journal-title":"J. Pharm. Sci."},{"key":"5184_CR55","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s40262-017-0525-5","volume":"56","author":"CP Hornik","year":"2017","unstructured":"Hornik, C. P. et al. Development of a pediatric physiologically-based pharmacokinetic model of clindamycin using opportunistic pharmacokinetic data. Clin. Pharmacokinet. 56, 1343\u20131353 (2017).","journal-title":"Clin. Pharmacokinet."},{"key":"5184_CR56","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/jp.2016.79","volume":"36","author":"N Thakkar","year":"2016","unstructured":"Thakkar, N. et al. An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. J. Perinatol. 36, 744\u2013747 (2016).","journal-title":"J. Perinatol."},{"key":"5184_CR57","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1128\/AAC.02374-13","volume":"58","author":"A Tremoulet","year":"2014","unstructured":"Tremoulet, A. et al. Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design. Antimicrob. Agents Chemother. 58, 3013\u20133020 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5184_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2004.08.044","volume":"502","author":"D Ma","year":"2004","unstructured":"Ma, D. et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur. J. Pharm. 502, 87\u201397 (2004).","journal-title":"Eur. J. Pharm."},{"key":"5184_CR59","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4103\/1673-5374.232529","volume":"13","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms. Neural Regen. Res. 13, 819\u2013826 (2018).","journal-title":"Neural Regen. Res."},{"key":"5184_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jclinane.2017.04.003","volume":"40","author":"L Jiang","year":"2017","unstructured":"Jiang, L. et al. The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis. J. Clin. Anesth. 40, 25\u201332 (2017).","journal-title":"J. Clin. Anesth."},{"key":"5184_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6643171","volume":"2021","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Dexmedetomidine alleviates hypoxia-induced synaptic loss and cognitive impairment via inhibition of microglial NOX2 activation in the hippocampus of neonatal rats. Oxidative Med. Cell. Longev. 2021, 6643171 (2021).","journal-title":"Oxidative Med. Cell. Longev."},{"key":"5184_CR62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/archdischild-2013-304037","volume":"98","author":"M Wan","year":"2013","unstructured":"Wan, M., Orlu-Gul, M., Legay, H. & Tuleu, C. Blinding in pharmacological trials: the devil is in the details. Arch. Dis. Child. 98, 656\u2013659 (2013).","journal-title":"Arch. Dis. Child."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05184-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:09:22Z","timestamp":1781651362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":62,"alternative-id":["5184"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05184-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki (Helsinki 5312-18-SMC) and approved by the Institutional Review Boards at the University of Utah (IRB_00136561) and Intermountain Health (IRB_1051818).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all parents\/guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}